GlaxoSmithKline (GSK.L) is buying Novartis (NOVN.S) out of their consumer healthcare joint venture for $13 billion, taking full control of products including Sensodyne toothpaste, Panadol headache tablets, muscle gel Voltaren, and Nicotinell patches.
{iframe}https://www.reuters.com/article/us-novartis-gsk/gsk-buys-out-novartis-in-13-billion-consumer-healthcare-shake-up-idUSKBN1H30FK{/iframe}